Internal Medicine, Cardiovascular Disease · Luling, LA
NPI
1669528915
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
107 Maryland Dr
Luling, LA, 70070
Phone (985) 308-1604
Groups this clinician bills Medicare through
Medicare paid, 2024
$578K
10,670 services
Medicare patients, 2024
742
Average age 75
Drug cost, 2024
$2.9M
17,145 prescriptions
Company payments, 2025
$1,442
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Owen Mogabgab was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 2,845 times for 28 patients. In total Owen Mogabgab billed 10,670 services in 133 codes, and Medicare paid $578K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,845 | 28 | $0.10 | $288 |
| 99214 Office E&M - Established | Office | 1,289 | 630 | $87.76 | $113K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,247 | 622 | $12.08 | $15K |
| 93000 Electrocardiogram | Office | 755 | 557 | $9.68 | $7,311 |
| 85027 Blood Count | Office | 379 | 327 | $6.34 | $2,403 |
| 80053 Clinical Chemistry | Office | 358 | 317 | $10.35 | $3,705 |
| 93306 Echocardiography (TTE/TEE) | Office | 347 | 343 | $126.20 | $44K |
| 80061 Clinical Chemistry | Office | 339 | 308 | $13.12 | $4,448 |
| 84443 Clinical Chemistry | Office | 323 | 299 | $16.46 | $5,317 |
| 83036 Blood Count | Office | 209 | 200 | $9.52 | $1,990 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 202 | 22 | $44.18 | $8,924 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 180 | 45 | $5.43 | $977 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 158 | 157 | $124.03 | $20K |
| 93018 Electrocardiogram | Office | 113 | 113 | $10.19 | $1,151 |
| 93922 Duplex Scan - Extremity Arteries | Office | 111 | 107 | $47.72 | $5,297 |
By year: 2022 $154K for 8,830 services; 2023 $625K for 9,188 services; 2024 $578K for 10,670 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85027 Blood Count | 379 | 327 | $6.34 | $2,403 |
| 80053 Clinical Chemistry | 358 | 317 | $10.35 | $3,705 |
| 80061 Clinical Chemistry | 339 | 308 | $13.12 | $4,448 |
| 84443 Clinical Chemistry | 323 | 299 | $16.46 | $5,317 |
| 83036 Blood Count | 209 | 200 | $9.52 | $1,990 |
| 80048 Clinical Chemistry | 96 | 74 | $8.29 | $796 |
| 83880 Clinical Chemistry | 41 | 29 | $38.47 | $1,577 |
Medicare prescription drug claims, 2024
In 2024, the drug Owen Mogabgab prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,026 prescriptions and refills. In total Owen Mogabgab wrote 17,145 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,026 | 5,372 | 572 | $24K |
| Clopidogrel Clopidogrel Bisulfate | 1,136 | 2,959 | 325 | $9,310 |
| Metoprolol Succinate Generic | 1,056 | 2,718 | 306 | $14K |
| Eliquis Apixaban | 1,056 | 1,702 | 200 | $969K |
| Amlodipine Besylate Generic | 885 | 2,310 | 250 | $4,069 |
| Carvedilol Generic | 771 | 1,964 | 220 | $5,868 |
| Atorvastatin Calcium Generic | 724 | 1,955 | 224 | $5,814 |
| Olmesartan Medoxomil Generic | 661 | 1,564 | 192 | $7,090 |
| Furosemide Generic | 469 | 1,003 | 153 | $1,226 |
| Amlodipine-Olmesartan Amlodipine Bes/Olmesartan Med | 455 | 982 | 126 | $14K |
| Repatha Sureclick Evolocumab | 437 | 750 | 92 | $428K |
| Spironolactone Generic | 411 | 1,004 | 125 | $2,795 |
| Ezetimibe Generic | 404 | 1,094 | 119 | $7,527 |
| Jardiance Empagliflozin | 326 | 512 | 76 | $288K |
| Pantoprazole Sodium Generic | 294 | 758 | 88 | $2,521 |
Brand drugs: - claims; generic drugs: 13,975 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Owen Mogabgab $1,442 ($1,442 in general payments such as food, travel and fees) from 16 companies. The largest payer was Novo Nordisk Inc with $271.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 3 | $271 |
| Medtronic, Inc. MDT | 3 | $242 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $170 |
| Abbott Laboratories ABT | 6 | $160 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $91.91 |
| Merck Sharp & Dohme LLC MRK | 5 | $90.15 |
| Surmodics, Inc. SRDX | 1 | $81.26 |
| Amgen Inc. AMGN | 5 | $79.76 |
| AngioDynamics, Inc. ANGO | 1 | $66.66 |
| Esperion Therapeutics, Inc. ESPR | 3 | $57.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.